Eli Lilly was hoping for even greater weight loss drug demand ...Middle East

Quartz - Economy
Eli Lilly was hoping for even greater weight loss drug demand

Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro.

Read more...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Eli Lilly was hoping for even greater weight loss drug demand )

    Also on site :



    Latest News